News

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract, and lung cancers. The combination of Imfinzi and Imjudo has been approved to treat unresectable hepatocellular...

Cellectis has entered into a strategic collaboration agreement with Primera Therapeutics to develop a gene editing platform to treat mitochondrial diseases. Primera Therapeutics is launched by Mayflower Bioventures, a cell and gene therapy accelerator stood up from Hibiscus BioVentures and...

BDR Pharmaceutical has launched the first generic apalutamide in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant prostate cancer. The product will be available across India and shall be of 60 mg strength...

Alligator Bioscience has expanded its research collaboration and license agreement with Orion Corp., a global pharmaceutical company based in Finland, to discover and develop new bispecific antibody cancer therapeutics. The collaboration has been expanded to add the development of a...

Polysciences, Inc., a Pennsylvania-based manufacturer of specialty chemicals for research, IVD and medical device applications, plans to create a new brand, Kyfora Bio, representing its product offerings to the bioprocessing market. Building on Polysciences’ experience in developing and manufacturing monomers,...

Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea. 1–3% of musicians worldwide suffer from musicians' dystonia, while 5% of all dystonia sufferers are musicians....

Atezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for adults and children two years of age and older who have ASPS that has migrated to other regions of...